Deal watch: Pfizer deal for selectin inhibitor highlights potential of glycomimetic drugs

Nat Rev Drug Discov. 2011 Dec 1;10(12):890. doi: 10.1038/nrd3622.
No abstract available

Publication types

  • News

MeSH terms

  • Biomimetics / trends*
  • Carbohydrates / chemical synthesis*
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Drug Design
  • Drug Discovery / trends*
  • Drug Industry / trends
  • Glycolipids / therapeutic use*
  • Humans
  • Selectins / metabolism*

Substances

  • Carbohydrates
  • Glycolipids
  • Selectins
  • rivipansel

Associated data

  • ClinicalTrials.gov/NCT01119833